Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

Extended report

Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction

Authors

M Bijl PubMed articles Google scholar articles
H Bootsma PubMed articles Google scholar articles
Y van der Geld PubMed articles Google scholar articles
P C Limburg PubMed articles Google scholar articles
C G M Kallenberg PubMed articles Google scholar articles
M H van Rijswijk PubMed articles Google scholar articles

Correspondence to:
Dr M Bijl
Department of Internal Medicine, Division of Clinical Immunology, University Hospital, PO Box 30.001, 9700 RB Groningen, Netherlands; m.bijlint.azg.nl

Citation

Bijl M, Bootsma H, van der Geld Y, et al

Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction

Annals of the Rheumatic Diseases 2004;63:831-835.

Publication history

Accepted August 24, 2003
First published June 11, 2004.

Online issue publication

April 07, 2023

Copyright information

Copyright 2004 by Annals of the Rheumatic Diseases